255 related articles for article (PubMed ID: 36562884)
41. Tau in Alzheimer disease and related tauopathies.
Iqbal K; Liu F; Gong CX; Grundke-Iqbal I
Curr Alzheimer Res; 2010 Dec; 7(8):656-64. PubMed ID: 20678074
[TBL] [Abstract][Full Text] [Related]
42. Pinning down phosphorylated tau and tauopathies.
Lim J; Lu KP
Biochim Biophys Acta; 2005 Jan; 1739(2-3):311-22. PubMed ID: 15615648
[TBL] [Abstract][Full Text] [Related]
43. The microtubule-associated protein tau is also phosphorylated on tyrosine.
Lebouvier T; Scales TM; Williamson R; Noble W; Duyckaerts C; Hanger DP; Reynolds CH; Anderton BH; Derkinderen P
J Alzheimers Dis; 2009; 18(1):1-9. PubMed ID: 19542604
[TBL] [Abstract][Full Text] [Related]
44. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
[TBL] [Abstract][Full Text] [Related]
45. Calpain-mediated tau cleavage: a mechanism leading to neurodegeneration shared by multiple tauopathies.
Ferreira A; Bigio EH
Mol Med; 2011; 17(7-8):676-85. PubMed ID: 21442128
[TBL] [Abstract][Full Text] [Related]
46. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention.
Iqbal K; Grundke-Iqbal I
J Cell Mol Med; 2008; 12(1):38-55. PubMed ID: 18194444
[TBL] [Abstract][Full Text] [Related]
47. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
[TBL] [Abstract][Full Text] [Related]
48. Downregulation of glob1 suppresses pathogenesis of human neuronal tauopathies in Drosophila by regulating tau phosphorylation and ROS generation.
Nisha ; Sarkar S
Neurochem Int; 2021 Jun; 146():105040. PubMed ID: 33865914
[TBL] [Abstract][Full Text] [Related]
49. Current strategies for the treatment of Alzheimer's disease and other tauopathies.
Dickey CA; Petrucelli L
Expert Opin Ther Targets; 2006 Oct; 10(5):665-76. PubMed ID: 16981824
[TBL] [Abstract][Full Text] [Related]
50. Modulating Protein Phosphatase 2A Rescues Disease Phenotype in Neurodegenerative Tauopathies.
McKenzie-Nickson S; Chan J; Perez K; Hung LW; Cheng L; Sedjahtera A; Gunawan L; Adlard PA; Hayne DJ; McInnes LE; Donnelly PS; Finkelstein DI; Hill AF; Barnham KJ
ACS Chem Neurosci; 2018 Nov; 9(11):2731-2740. PubMed ID: 29920069
[TBL] [Abstract][Full Text] [Related]
51. The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation.
Plattner F; Angelo M; Giese KP
J Biol Chem; 2006 Sep; 281(35):25457-65. PubMed ID: 16803897
[TBL] [Abstract][Full Text] [Related]
52. Recent developments with tau-based drug discovery.
Iqbal K; Liu F; Gong CX
Expert Opin Drug Discov; 2018 May; 13(5):399-410. PubMed ID: 29493301
[TBL] [Abstract][Full Text] [Related]
53. [Neuropathology of tauopathy].
Yoshida M
Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
[TBL] [Abstract][Full Text] [Related]
54. RPS23RG1 modulates tau phosphorylation and axon outgrowth through regulating p35 proteasomal degradation.
Zhao D; Zhou Y; Huo Y; Meng J; Xiao X; Han L; Zhang X; Luo H; Can D; Sun H; Huang TY; Wang X; Zhang J; Liu FR; Xu H; Zhang YW
Cell Death Differ; 2021 Jan; 28(1):337-348. PubMed ID: 32908202
[TBL] [Abstract][Full Text] [Related]
55. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
Vingtdeux V; Davies P; Dickson DW; Marambaud P
Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
[TBL] [Abstract][Full Text] [Related]
56. Pharmacological approaches of neurofibrillary degeneration.
Iqbal K; Grundke-Iqbal I
Curr Alzheimer Res; 2005 Jul; 2(3):335-41. PubMed ID: 15974899
[TBL] [Abstract][Full Text] [Related]
57. Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease.
Iqbal K; Gong CX; Liu F
Expert Opin Ther Targets; 2014 Mar; 18(3):307-18. PubMed ID: 24387228
[TBL] [Abstract][Full Text] [Related]
58. Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?
Alavi Naini SM; Soussi-Yanicostas N
Oxid Med Cell Longev; 2015; 2015():151979. PubMed ID: 26576216
[TBL] [Abstract][Full Text] [Related]
59. Targeted Downregulation of dMyc Suppresses Pathogenesis of Human Neuronal Tauopathies in Drosophila by Limiting Heterochromatin Relaxation and Tau Hyperphosphorylation.
Chanu SI; Sarkar S
Mol Neurobiol; 2017 May; 54(4):2706-2719. PubMed ID: 27000837
[TBL] [Abstract][Full Text] [Related]
60. Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury?
Collins-Praino LE; Corrigan F
Brain Behav Immun; 2017 Feb; 60():369-382. PubMed ID: 27686843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]